Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism

Combining anticatabolic agents with parathyroid hormone (PTH) to enhance bone mass has yielded mixed results in osteoporosis patients. Toward the goal of enhancing the efficacy of these regimens, we tested their utility in combination with loss of the transcription factor Nmp4 because disabling this...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Endocrinology
Main Authors: Shao, Yu, Hernandez-Buquer, Selene, Childress, Paul, Stayrook, Keith R., Alvarez, Marta B., Davis, Hannah, Plotkin, Lilian I., He, Yongzheng, Condon, Keith W., Burr, David B., Warden, Stuart J., Robling, Alexander G., Yang, Feng-Chun, Wek, Ronald C., Allen, Matthew R., Bidwell, Joseph P.
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2017
Teme:
Research Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5659666/
https://ncbi.nlm.nih.gov/pubmed/28637206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2017-00355
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki